ACELYRIN (Nasdaq: SLRN) received unsolicited offer from Concentra Biosciences, LLC for $3.00 per share.
From GlobeNewswire: 2025-02-20 21:00:00 ACELYRIN, INC. (Nasdaq: SLRN) received an unsolicited offer from Concentra Biosciences, LLC to acquire all outstanding